These results indicate nuciferine could be an effective supplementary agent with YAP inhibition by the AMPK-mediated down-regulation of HMGCR, which may sensitize pancreatic cancer cells to gemcitabine [20]. This evidence concerns the gene HMGCR and familial pancreatic carcinoma.